To access this element change to forms mode OFF
Grant Award View - GA30132
CSF1 Therapy for Chronic Liver Disease
GA ID:
GA30132
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$497,127.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
CSF1 Therapy for Chronic Liver Disease
Purpose:
Chronic liver disease (CLD) is a major health burden. The defining feature of CLD is scarring of the liver (fibrosis), which can lead to loss of liver function and death. Macrophages are cells of the immune system that play critical roles in both fibrosis progression and fibrosis resolution. We have identified a growth factor that may switch pro-fibrotic macrophages to anti-fibrotic macrophages. In this Project we will investigate the therapeutic potential of this growth factor in CLD.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1162171
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD
Postcode:
Country:
AUSTRALIA